No official summary available for this bill.
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 919 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. RES. 919
Commemorating and supporting the goals of World AIDS Day.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
December 2, 2025
Mr. Pocan (for himself, Mr. Fitzpatrick, Ms. Barragan, Ms. Brownley,
Mr. Cohen, Mr. Davis of Illinois, Mr. Johnson of Georgia, Ms. Kelly of
Illinois, Ms. Moore of Wisconsin, Ms. Norton, Mr. Quigley, Ms. Sewell,
Mr. Soto, Mr. Thanedar, Mr. Torres of New York, Ms. Velazquez, and Mrs.
Watson Coleman) submitted the following resolution; which was referred
to the Committee on Energy and Commerce, and in addition to the
Committee on Foreign Affairs, for a period to be subsequently
determined by the Speaker, in each case for consideration of such
provisions as fall within the jurisdiction of the committee concerned
_______________________________________________________________________
RESOLUTION
Commemorating and supporting the goals of World AIDS Day.
Whereas, as of the end of 2024, an estimated 40,800,000 people were living with
human immunodeficiency virus (referred to in this preamble as ``HIV'')
or acquired immunodeficiency syndrome (referred to in this preamble as
``AIDS''), including 1,400,000 children;
Whereas, in the United States, more than 790,000 people with AIDS have died
since the beginning of the HIV epidemic, including over 19,300 deaths
among people with diagnosed HIV in 2022, with the disease
disproportionately affecting communities of color;
Whereas, in 2023, over 39,000 people became newly diagnosed with HIV in the
United States;
Whereas, according to the Centers for Disease Control and Prevention (referred
to in this preamble as the ``CDC''), Black Americans, Hispanic
Americans, Asian Americans, American Indians, Alaska Natives, Native
Hawaiians, and other Pacific Islanders are disproportionately affected
by HIV in the United States;
Whereas, in order to address the HIV epidemic in the United States, on August
18, 1990, Congress enacted the Ryan White Comprehensive AIDS Resources
Emergency Act (Public Law 101-381; 104 Stat. 576) (commonly referred to
as the ``Ryan White CARE Act'') to provide primary medical care and
essential support services for people living with HIV who are uninsured
or underinsured;
Whereas the Ryan White HIV/AIDS Program provides services and support for over
half of all people diagnosed with HIV in the United States;
Whereas, to further focus attention on the HIV and AIDS epidemic among minority
communities in the United States, in 1998, the Minority AIDS Initiative
was established to provide funds to State and local institutions and
organizations to best serve the needs of racial and ethnic minorities
living with HIV;
Whereas, since 2016, the historic U=U (Undetectable=Untransmittable) movement
has positively impacted the lives of people living with HIV by promoting
scientific facts;
Whereas, when people living with HIV are on treatment and have an undetectable
viral load, they protect their own health and cannot transmit HIV;
Whereas the United Nations Sustainable Development Goals established a global
target to end AIDS as a public health threat by 2030;
Whereas, in order to further address the global HIV and AIDS epidemic, in 2003,
Congress and the administration of President George W. Bush, with
bipartisan support, created the President's Emergency Plan for AIDS
Relief (referred to in this preamble as ``PEPFAR'');
Whereas the United States PEPFAR program remains the largest commitment in
history by any country to combat a single disease;
Whereas 26,000,000 lives have been saved through PEPFAR;
Whereas, as of September 30, 2024, PEPFAR has supported treatment for
approximately 20,600,000 people and has enabled 7,800,000 infants of
mothers living with HIV to be born HIV-free;
Whereas, in fiscal year 2024, PEPFAR directly supported testing and counseling
for 84,100,000 people;
Whereas sustained bipartisan commitment is essential for PEPFAR to continue
saving lives, preventing new HIV infections, and accelerating progress
toward controlling the global HIV and AIDS pandemic;
Whereas the Global Fund to Fight AIDS, Tuberculosis and Malaria, launched in
2002, has helped provide antiretroviral therapy to approximately
25,600,000 people living with HIV or AIDS and to 648,000 pregnant women
to prevent the transmission of HIV and AIDS to their children and, as of
2025, has saved an estimated 70,000,000 lives;
Whereas the United States is the largest donor to the Global Fund to Fight AIDS,
Tuberculosis and Malaria, and every $1 contributed by the United States
leverages an additional $2 from other donors, as required by law;
Whereas considerable progress has been made in the fight against HIV and AIDS,
including an approximately 40-percent reduction in new HIV
transmissions, an approximately 60-percent reduction in new HIV
infections among children, and a reduction of over 50 percent in the
number of AIDS-related deaths between 2010 and 2024;
Whereas approximately 31,600,000 people had access to antiretroviral therapy in
2024, compared to only 7,700,000 people who had access to such therapy
in 2010;
Whereas research funded by the National Institutes of Health found not only that
HIV treatment saves the lives of people living with HIV, but people
living with HIV on effective antiretroviral therapy and who are durably
virally suppressed cannot sexually transmit HIV, proving that HIV
treatment is prevention;
Whereas the CDC states that preexposure prophylaxis (referred to in this
preamble as ``PrEP'') reduces HIV transmission through sexual contact by
99 percent when taken as prescribed, proving that PrEP is critical for
HIV prevention;
Whereas, in 2024, approximately 3,900,000 people globally used oral PrEP;
Whereas new, long-acting injectable PrEP options are now available;
Whereas it is estimated that, without treatment, half of all infants living with
HIV will die before their second birthday;
Whereas, despite the remarkable progress in combating HIV, significant
challenges remain;
Whereas, in 2024, there were approximately 1,300,000 new HIV diagnoses globally,
structural barriers continue to make testing and treatment programs
inaccessible to highly vulnerable populations, and an estimated
5,300,000 people living with HIV globally still do not know their HIV
status;
Whereas the CDC reports that over 39,000 people were diagnosed with HIV in the
United States in 2023, and 13 percent of the 1,200,000 people in the
United States living with HIV are not aware of their HIV status;
Whereas the CDC has found that men who have sex with men, particularly young
Black and Hispanic men, are the population disproportionately affected
by HIV in the United States;
Whereas Southern States bear the greatest burden of HIV in the United States,
accounting for 52 percent of all diagnoses in 2022;
Whereas transgender feminine individuals are 66 times more likely, and
transgender masculine individuals are 6.8 times more likely, to be
diagnosed with HIV compared to the general adult population;
Whereas 1 in 2 people living with HIV in the United States are over 50;
Whereas people living with HIV are frequently susceptible to other infections,
such as hepatitis B and C and tuberculosis;
Whereas the opioid and heroin epidemics have led to increased numbers of new HIV
infections among people who inject drugs, and the crisis has
disproportionately affected nonurban areas, where HIV prevalence rates
have been low historically and services for HIV prevention and treatment
and substance use disorder treatment are limited;
Whereas December 1 of each year is internationally recognized as ``World AIDS
Day'';
Whereas 2025 marks the 22nd anniversary of the PEPFAR program, an initiative
launched by President George W. Bush with bipartisan support that has
become the primary policy instrument of the United States to address HIV
and AIDS globally; and
Whereas, in 2025, commemorations for World AIDS Day will recognize the essential
role of community and collective action to sustain and accelerate HIV
progress in the global HIV and AIDS response: Now, therefore, be it
Resolved, That the House of Representatives--
(1) encourages people around the world to work to achieve
the goal of 0 new human immunodeficiency virus (referred to in
this resolution as ``HIV'') transmissions, 0 discrimination,
and 0 deaths related to acquired immunodeficiency syndrome
(referred to in this resolution as ``AIDS''), in order to end
the HIV epidemic in the United States and around the world by
2030;
(2) encourages Federal, State, and local governments,
including their public health agencies, and community-based
organizations to share and disseminate U=U
(Undetectable=Untransmittable) information;
(3) commends the efforts and achievements in combating HIV
and AIDS through the Ryan White HIV/AIDS Treatment Extension
Act of 2009 (Public Law 111-87; 123 Stat. 2885), the Minority
HIV/AIDS Initiative, the Housing Opportunities for Persons With
AIDS Program, the Centers for Disease Control and Prevention,
the National Institutes of Health, the Substance Abuse and
Mental Health Services Administration, the Office of Minority
Health, and the Office of the Secretary of Health and Human
Services;
(4) commends the efforts and achievements in combating HIV
and AIDS made by the President's Emergency Plan for AIDS Relief
(referred to in this resolution as ``PEPFAR'' ), the Global
Fund to Fight AIDS, Tuberculosis and Malaria, and the Joint
United Nations Programme on HIV/AIDS;
(5) supports continued funding for prevention, care, and
treatment services and research programs for communities
impacted by HIV and people living with HIV in the United States
and globally;
(6) urges, in order to ensure that an AIDS-free generation
is achievable, rapid action by all countries toward further
expansion and scale-up of antiretroviral treatment and
prevention programs, including efforts to reduce disparities
and improve access to life-saving medications for children;
(7) encourages the scaling up of comprehensive prevention
services, including biomedical and structural interventions and
new long-acting preexposure prophylaxis options, to ensure
inclusive access to programs and appropriate resources for all
people at risk of contracting HIV, especially in communities
disproportionately impacted by the disease, as these groups
make up the majority of new HIV diagnoses in the United States
and prevention efforts should specifically reach these groups;
(8) supports the robust funding of all aspects of research
and development of the next generation of treatment and
prevention options through the National Institutes of Health
and partner institutions, including the development of a
vaccine and cure for HIV, as well as treatment and prevention
options for significant HIV comorbidities, such as sexually
transmitted infections and tuberculosis;
(9) calls for renewed focus on HIV-related vulnerabilities
of women and girls, including women and girls at risk for, or
who have survived, violence or faced discrimination as a result
of the disease;
(10) supports continued leadership by the United States in
domestic, bilateral, multilateral, and private sector efforts
to fight HIV;
(11) encourages input from civil society in the development
and implementation of domestic and global HIV policies and
programs that guide the response to the disease with specific
measures for transparency and accountability;
(12) encourages and supports greater degrees of ownership
and shared responsibility by developing countries in order to
ensure the sustainability of the domestic responses to HIV by
those countries; and
(13) urges other members of the international community to
sustain and scale up their support for, and financial
contributions to, efforts around the world to combat HIV.
<all>
Submitted in House
Submitted in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line